image
Karyopharm Therapeutics Inc. KPTI
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.814
-2.78 %
$ 102 M
Market Cap
-0.78
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -7.03% 13.43% 8.90%
Annual Report FY 10-K 2022-12-31 -25.14% -33.20% -44.70%
Annual Report FY 10-K 2021-12-31 94.12% 36.78% 42.82%
Annual Report FY 10-K 2020-12-31 164.31% 1.66% 9.21%
Annual Report FY 10-K 2019-12-31 34.80% -11.87% -5.22%
Annual Report FY 10-K 2018-12-31 1790.09% -38.32% -37.80%
Annual Report FY 10-K 2017-12-31 942.21% -17.71% -17.89%
Annual Report FY 10-K 2016-12-31 -38.40% 7.28% 7.01%
Annual Report FY 10-K 2015-12-31 9.17% -55.96% -57.00%
Annual Report FY 10-K 2014-12-31 -40.83% -123.22% -123.41%
Annual Report FY 10-K 2013-12-31 -38.96% -113.66% -113.66%
Annual Report FY 10-K 2012-12-31 317.11% -54.09% -54.11%
Annual Report FY 10-K 2011-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 7.70% 7.05% 15.92%
Quarterly Report Q2 8-K 2024-06-30 13.86% 172.91% 4.91%
Quarterly Report Q1 8-K 2024-03-31 -14.40% -9.48% -9.26%
Quarterly Report Q4 8-K 2023-12-31 0.50% -8.65% -11.63%
Quarterly Report Q3 8-K 2023-09-30 -0.38% 5.00% -1.37%
Quarterly Report Q2 8-K 2023-06-30 -5.29% 33.49% 31.08%
Quarterly Report Q1 8-K 2023-03-31 -18.82% 17.57% 10.66%
Quarterly Report Q4 8-K 2022-12-31 -73.41% -99.45% -72.12%
Quarterly Report Q3 8-K 2022-09-30 -4.10% 29.89% 29.61%
Quarterly Report Q2 8-K 2022-06-30 75.56% 8.44% 12.52%
Quarterly Report Q1 8-K 2022-03-31 104.94% 27.89% 33.96%
Quarterly Report Q4 8-K 2021-12-31 259.74% 189.17% 226.70%
Quarterly Report Q3 8-K 2021-09-30 76.67% 3.15% 7.00%
Quarterly Report Q2 8-K 2021-06-30 -32.56% -15.41% -21.65%
Quarterly Report Q1 8-K 2021-03-31 28.24% -8.47% -10.59%
Quarterly Report Q4 8-K 2020-12-31 93.97% 10.74% 14.33%
Quarterly Report Q3 8-K 2020-09-30 62.24% -29.32% -19.56%
Quarterly Report Q2 8-K 2020-06-30 253.04% -6.94% 3.28%
Quarterly Report Q1 8-K 2020-03-31 11601.94% 20.00% 27.06%
Quarterly Report Q4 8-K 2019-12-31 8684.47% 16.43% 24.70%
Quarterly Report Q3 8-K 2019-09-30 5401.67% 13.97% 19.84%
Quarterly Report Q2 8-K 2019-06-30 -52.27% -29.00% -21.42%
Quarterly Report Q1 8-K 2019-03-31 -98.45% -72.03% -66.71%
Quarterly Report Q4 8-K 2018-12-31 -86.57% -49.10% -45.63%
Quarterly Report Q3 8-K 2018-09-30 0.00% -56.93% -58.28%
Quarterly Report Q2 8-K 2018-06-30 662933.33% -14.52% -15.39%
Quarterly Report Q1 8-K 2018-03-31 14605.88% -28.55% -28.61%
Quarterly Report Q4 8-K 2017-12-31 3163.83% -44.94% -45.23%
Quarterly Report Q3 8-K 2017-09-30 0.00% -20.51% -20.64%
Quarterly Report Q2 8-K 2017-06-30 -94.92% 2.56% 2.38%
Quarterly Report Q1 8-K 2017-03-31 0.00% -10.56% -10.71%
Quarterly Report Q4 8-K 2016-12-31 88.00% 7.27% 7.30%
Quarterly Report Q3 8-K 2016-09-30 -36.00% 16.29% 15.90%
Quarterly Report Q2 8-K 2016-06-30 -60.67% 7.76% 7.68%
Quarterly Report Q1 8-K 2016-03-31 0.00% -3.81% -4.59%
Quarterly Report Q4 8-K 2015-12-31 56.25% -12.03% -12.96%
Quarterly Report Q3 8-K 2015-09-30 257.14% -53.99% -55.03%
Quarterly Report Q2 8-K 2015-06-30 614.29% -98.98% -100.71%
Quarterly Report Q1 8-K 2015-03-31 0.00% -90.35% -90.71%
Quarterly Report Q4 8-K 2014-12-31 -23.81% -113.47% -113.55%
Quarterly Report Q3 8-K 2014-09-30 0.00% -111.61% -111.82%
Quarterly Report Q2 8-K 2014-06-30 -84.21% -139.21% -139.42%
Quarterly Report Q1 8-K 2014-03-31 -26.61% -144.06% -144.38%
Quarterly Report Q4 8-K 2013-12-31 -36.36% -186.60% -186.64%
Quarterly Report Q3 8-K 2013-09-30 0.00% -156.42% -156.42%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%